Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease

Part of paid clinical trials in New York, New York.

Sponsor
Teachers College, Columbia University
Study ID
NCT06540989
Phase
EARLY_PHASE1
Status
Recruiting
Apply to this trial

Conditions

Eligibility Criteria

Sex
ALL
Age
50 Years - 80 Years
Healthy Volunteers
Not accepted

Interventions

  • Immediate treatment — BEHAVIORAL
    Participants will access a web-based app using their phone to record 100 sentences every treatment session. Noise-augmented feedback will be provided to increase accuracy of speech productions.
  • Deferred treatment — BEHAVIORAL
    This group of participants will receive the same treatment as those in the immediate treatment group. The only difference is the timeline of treatment onset. Therefore, participants will access a web-based app using their phone to record 100 sentences every treatment session. Noise-augmented feedback will be provided to increase accuracy of speech productions.

Study Details

The goal of this clinical trial is to learn whether noise-augmented feedback using automatic speech recognition improves intelligibility and social participation in individuals with Parkinson's disease. The main questions the investigators will address are: Does noise-augmented feedback lead to increased intelligibility, as measured by transcription accuracy scores? Does a self-managed speech protocol lead to increased social participation, as measured by the Communicative Participation Item Bank and the Communicative Effectiveness Index questionnaires? Participants will: Receive 2-4 initial speech assessments in-person in our lab. Engage in speech treatment sessions at home using their phone and computer four days a week for four weeks. Four of those sessions will be directly monitored online by a speech-language pathologist. The rest of the sessions are completed by the participant. Come to the lab for two post-treatment assessments following completion of treatment. Come to the lab six months after treatment completion for an additional assessment.

Key Dates

Start date
Sep 1, 2024
Status verified
Aug 2024
Primary completion
Jan 31, 2026
Completion
Jun 30, 2027

Study Design

Enrollment
42 participants (estimated)
Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT

Arms

  • Experimental: Immediate treatment
    Participants will receive speech treatment immediately after their second pre-treatment assessment.
  • Active Comparator: Deferred treatment
    Participants will receive speech treatment one month after their second pre-treatment assessment. This arm receives the same speech treatment as Arm 1.

Primary Outcome Measure

Intelligibility [ Time Frame: 3 years ]

Central Contacts

Locations (1)

FacilityCityStateZIPSite coordinators
Teachers College, Columbia UniversityNew YorkNew York10027
Gemma Moya-Galé, Ph.D.
[email protected]
212-678-3323

Find similar trials in New York, NY

By condition
Parkinson's disease
By specialty
NeurologyBrain disorders
By research site
Teachers College, Columbia University· New York, NY

Related Studies